ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Free Trade Agrements - Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL HEAD | — |
| KATHLEEN D JAEGER | — |
| CHARLES L KINNEY | — |
| JASON R MONEY | — |
Pharmacy PHA
Generic Biologics, Health Care Reform, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Authorized Generics, Prescription Drug Importation/Re-Importation, 340B Drug Pricing Program, and generic drugs H.R.1427 and S.726 - Promoting Innovation and Access to Life-Saving Medicines Act, all provisions H.R.1548 - Pathway for Biosimilars Act, all provisions H.R.573, all provisions S.501 - Fair Prescription Drug Competition Act, all provisions S.882 - Drug and Device Accountability Act of 2009, Title I Subtitle A, B, C, and D and Title II H.R. 759 - Food and Drug Administration Globalization Act of 2009, Title II S.525, S.1232, and H.R.1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act, Title VII - Improving Access to Innovative Medical Therapies H.R.3962 - Affordable Health Care for America Act, Title I Subtitle B Part 3 Section 1149A - Payment for Biosimilar Biological Products; Title V Subtitle C Part 2 - Biosimilars
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL HEAD | — |
| KATHLEEN D JAEGER | — |
| CHARLES L KINNEY | — |
| JASON R MONEY | — |
Copyright/Patent/Trademark CPT
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent term extensions, Generic drugs S.515, S.610 and H.R.1260 - the Patent Reform Act of 2009, all provisions S.369 - Preserve Access to Affordable Generics Act, all provisions H.R.1706 - Protecting Consumers Access to Generic Drugs Act of 2009, all provisions H.R.3590 - Patient Protection and Affordable Care Act, Title VII Subtitle A - Biologics Price Competition and Innovation H.R.3962 - Affordable Health Care for America Act, Title V Subtitle C Part 2 - Biosimilars; Subtitle C Part 1 Section 2573 - Protecting Consumer Access to Generic Drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL HEAD | — |
| KATHLEEN D JAEGER | — |
| CHARLES L KINNEY | — |
| JASON R MONEY | — |
Medicare/Medicaid MMM
Medicaid Reimbursement, Medicaid Rebates, The Deficit Reduction Act of 2006, prescription drug reimbursement, Average Manufacture Price (AMP)/AMP Publication, Expanding rebates to Part D program, generic drugs H.R.3962 - Affordable Health Care for America Act - Title I, Subtitle E - Improvements to Medicare Part D; Title V Subtitle A - Drug Discount for Rural and Other Hospitals; 340B Program Integrity; Title VII Subtitle E - Financing; H.R.3590 - Patient Protection and Affordable Care Act; Title II Subtitle F - Medicaid Prescription Drug Coverage; Title VII Subtitle B - More Affordable Medicines for Children and Underserved Communities
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL HEAD | — |
| KATHLEEN D JAEGER | — |
| CHARLES L KINNEY | — |
| JASON R MONEY | — |
Budget/Appropriations BUD
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY2010 Presidential Budget Request, FY2010 Congressional Budget and Appropriations H.R.2997 and S.1406 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010 - Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL HEAD | — |
| KATHLEEN D JAEGER | — |
| CHARLES L KINNEY | — |
| JASON R MONEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.